September 17, 2020
Proniras Corporation Announces National Institute on Drug Abuse (NIDA) Grant Award to Pursue Treatment for Opioid Withdrawal
August 31, 2020
Rodeo Therapeutics Nominates First-in-Class Oral Development Candidate for Inflammatory Bowel Disease
December 20, 2019
Lodo Therapeutics Names Serial Biotech Entrepreneur Dale Pfost As CEO And Adds Top Industry Veterans To Leadership Team
August 13, 2018
Accelerator Life Science Partners Launches Magnolia Neurosciences Corporation with $31 Million Series A to Develop Targeted Neuroprotective Therapies
May 15, 2018
Accelerator Life Science Partners Broadens its Leadership Teams and Expands its Geographic Operations to San Diego and the Greater Los Angeles Area
May 9, 2018
Lodo Therapeutics Corporation Forms Multi-Target Strategic Collaboration with Genentech
April 27, 2018
Accelerator Life Science Partners Launches Proniras Corporation to Support Development of Tezampanel in the Treatment of Seizure Disorders
April 27, 2018
Proniras Corporation Awarded Contract Worth Up to $89.5 Million from U.S. Biomedical Advanced Research and Development Authority to Develop Tezampanel as a Medical Countermeasure for Nerve Agent-Induced Seizures
December 13, 2017
Accelerator Corporation Announces Key Senior Leadership Appointments and Name Change to Accelerator Life Science Partners
July 25, 2017
Accelerator Corporation Announces Series A Financing in Rodeo Therapeutics to Focus on Small-Molecule Regenerative Therapies
December 12, 2016
Accelerator Corporation Announces $7M Series A Investment in ApoGen Biotechnologies to Develop a New Class of Drugs Targeting Resistance to Cancer Therapy
October 20, 2016
Accelerator Corporation Expands Operations with New Research Institution Partners
January 11, 2016
Accelerator Corporation Launches Lodo Therapeutics with $17 Million Series A to Develop Therapies Derived from Natural Products
January 11, 2016
Accelerator Corporation Launches Lodo Therapeutics with $17 Million Series A to Develop Therapies Derived from Natural Products
January 6, 2016
Accelerator Corporation Launches First Startup in New York City Portfolio
September 29, 2015
Accelerator Corporation Completes $62.8 Million Oversubscribed Financing
July 29, 2014
Accelerator Corporation Secures $51.1 Million to Support Emerging Biotechnology Research Opportunities in New York City and Seattle
March 31, 2021
Amgen takes a swing at regenerative immunology with $721M acquisition of Rodeo Therapeutics
March 30, 2021
Amgen Acquires Rodeo, Lean Startup With Dual Mechanism for Crohn’s, Colitis
May 1, 2019
Taking Aim at Peripheral Neuropathy and Neurodegeneration Targets
April 2, 2019
Seattle startup Rodeo Therapeutics raises more cash for regenerative medicine treatments
January 8, 2018
Alexandria Venture Investments Launches the Alexandria Seed Capital Platform, a Novel and Innovative Seed-Stage Life Science Funding Model and a Natural Extension of Alexandria LaunchLabs
December 14, 2017
Accelerator Corp. announces new leadership and renames to Accelerator Life Science Partners
December 14,, 2017
Accelerator, Backed by Corporate VCs, Spreads Wings – But Not in Boston & SF
January 6, 2016
Accelerator Corporation Launches First Startup in New York City Portfolio
January 28, 2014
A new approach to biotech investing: Accelerator Corp. brings in new CEO
July 29, 2014
Wanted: Biotech Startups in New York City: The Alexandria Center for Life Science Looks to Expand